Trump to unveil new deals to cut drug prices
'The Big Money Show' panel weighs in on President Donald Trump's anticipated announcement regarding lowering drug prices as well as health care system.
GOP lawmaker flags sharp rise in insurer profits tied to Obamacare
Rep. Lisa McClain, R-Mich., joins 'Varney & Co.' to break down the GOP health care bill, the future of Obamacare extensions, and President Donald Trump’s economic message during his address to the nation.
GOP lawmaker: These Covid-era fraud-ridden subsidies have made health care more expensive
Rep. Jodey Arrington, R-Texas, lays out the Republicans' plan for health care and weighs in on Vice President JD Vance's remarks on the economy on 'Varney & Co.'
Congress won't fix 'exploding' healthcare premiums this year: Chad Pergram
Fox News chief congressional correspondent Chad Pergram reports on the latest in the debate over Obamacare subsidy extensions on 'Varney & Co.'
FDA commissioner unveils major reform to fast-track drug innovation
FDA Commissioner Dr. Marty Makary joins 'Varney & Co.' to discuss the FDA's plan to cut red tape, declining men's testosterone levels and his visit to Novartis' manufacturing site.
Trump administration backs Bayer as Roundup fight moves toward Supreme Court
The Trump administration backs Bayer's Supreme Court bid to curb Roundup cancer lawsuits, potentially affecting thousands of pending legal cases nationwide.
Robotics is a 'big macro trend' in healthcare, says Medtronic CEO
Medtronic Chairman and CEO Geoffrey Martha discusses the company’s latest robotic innovation and how robotics can impact healthcare on 'The Claman Countdown.'
Inside Trump’s plan to make housing and health insurance more affordable
FOX Business' Edward Lawrence reports from the White House on President Donald Trump’s push to lower costs through competition-based health insurance and affordable housing initiatives.
Trump announces 'drastic discounts' for weight-loss drugs
Medicare and Medicaid Services Administrator Dr. Mehmet Oz discusses President Donald Trump's plan to lower the cost of weight-loss drugs on 'Varney & Co.'
Obamacare prices are set to spike – here's why
Obamacare health insurance premiums are expected to rise 26% on average in 2026 as Congress debates extending enhanced premium tax credits amid the government shutdown.
Dr. Marc Siegel: I like AI as a co-pilot
NYU Langone Health professor of medicine Dr. Marc Siegel discusses whether it's safe for patients to get A.I. medical advice on 'Varney & Co.'
Rep. Chip Roy sounds off on health insurance companies' 'free money'
Rep. Chip Roy, R-Texas, addresses what is at the center of Congress' shutdown fight on 'The Bottom Line.'
AstraZeneca CEO says drug cost announcement is 'about putting President Trump's vision into action'
AstraZeneca CEO Pascal Soriot breaks down the agreement with the U.S. to lower drug costs as well as their investments in the states on 'Maria Bartiromo's Wall Street.'
Trump announces drug-pricing deal with AstraZeneca
President Trump details a new drug-pricing deal with AstraZeneca, and Fox News political analyst Lisa Boothe reacts on 'The Evening Edit.'
Stephen Moore exposes the ‘ultimate irony’ of the Affordable Care Act
Committee to Unleash Prosperity co-founder Stephen Moore reacts to a Washington Post op-ed admitting the Affordable Care Act was never affordable and breaks down the costs of NYC mayoral candidate Zohran Mamdani’s agenda on 'The Bottom Line.'
Trump admin move reflects an even wider issue on trust in Big Pharma: Charles Payne
'Making Money' host Charles Payne discusses trust and satisfaction when it comes to health care amid the anticipated Trump administration announcement on autism.
RFK Jr. wants to 'empower the patient,' GOP senator says
Senator Roger Marshall, R-Kans., discusses the CDC's vaccine review meeting and the relationship between pharmaceutical companies, doctors and the government on 'The Bottom Line.'
CVS Caremark ordered to pay $290M after Medicare fraud scheme exposed by former Aetna whistleblower
Whistleblower Sarah Behnke's lawsuit leads to a $290 million judgment against CVS Caremark for overcharging Medicare on prescription drugs in 2013 and 2014.
FTC secures $145M settlement from companies that allegedly deceived health insurance shoppers with robocalls
FTC reaches $145 million settlement with Assurance IQ and MediaAlpha over allegations of misleading consumers about healthcare services and illegal robocalls.
SandboxAQ partners with iOncologi to accelerate brain cancer treatment development
SandboxAQ CEO Jack Hidary explains how A.I. can be used to discover new brain cancer therapeutics on 'Mornings with Maria.'




















